TG Therapeutics Inc (NASDAQ: TGTX) on Monday, plunged -6.02% from the previous trading day, before settling in for the closing price of $32.24. Within the past 52 weeks, TGTX’s price has moved between $25.28 and $46.48.
The company achieved an average annual earnings per share of 1902.86%. With a float of $143.00 million, this company’s outstanding shares have now reached $155.21 million.
TG Therapeutics Inc (TGTX) Insider Updates
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of TG Therapeutics Inc is 9.93%, while institutional ownership is 63.45%. The most recent insider transaction that took place on Sep 11 ’25, was worth 672,268. In this transaction Director of this company sold 20,852 shares at a rate of $32.24, taking the stock ownership to the 94,061 shares. Before that another transaction happened on Sep 11 ’25, when Company’s Director proposed sale 20,852 for $32.24, making the entire transaction worth $672,233.
TG Therapeutics Inc (TGTX) Performance Highlights and Predictions
As on 12/31/2024, Multinational firm has announced its last quarter scores, in which it reported 0.15 earnings per share (EPS) for the period falling under the consensus outlook (set at 0.2) by -0.05. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.39 per share during the current fiscal year.
TG Therapeutics Inc (NASDAQ: TGTX) Trading Performance Indicators
TG Therapeutics Inc (TGTX) is currently performing well based on its current performance indicators. A quick ratio of 2.89 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.04.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.78, a number that is poised to hit 0.33 in the next quarter and is forecasted to reach 1.84 in one year’s time.
Technical Analysis of TG Therapeutics Inc (TGTX)
Let’s dig in a bit further. During the last 5-days, its volume was 2.36 million. That was inferior than the volume of 2.36 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 22.50%.
During the past 100 days, TG Therapeutics Inc’s (TGTX) raw stochastic average was set at 34.74%, which indicates a significant increase from 7.30% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.85 in the past 14 days, which was higher than the 1.37 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $33.93, while its 200-day Moving Average is $34.98. However, in the short run, TG Therapeutics Inc’s stock first resistance to watch stands at $31.86. Second resistance stands at $33.42. The third major resistance level sits at $34.45. If the price goes on to break the first support level at $29.27, it is likely to go to the next support level at $28.24. Assuming the price breaks the second support level, the third support level stands at $26.68.
TG Therapeutics Inc (NASDAQ: TGTX) Key Stats
Market capitalization of the company is 4.81 billion based on 158,759K outstanding shares. Right now, sales total 329,000 K and income totals 23,380 K. The company made 141,150 K in profit during its latest quarter, and 28,190 K in sales during its previous quarter.
